このエントリーをはてなブックマークに追加
ID 31977
JaLCDOI
FullText URL
fulltext.pdf 3.94 MB
Author
Mikuniya, Takeshi
Kato, Yoshihisa
Monden, Koichi
Hikida, Muneo
Kumon, Hiromi Kaken ID publons
Abstract

Ulifloxacin is the active form of the prodrug prulifloxacin and shows a highly potent antipseudomonal activity. In this study, we examined the combined effect of fosfomycin and ulifloxacin against Pseudomonas aeruginosa (P. aeruginosa) growing in a biofilm using a modified Robbins device with artificial urine, and compared it to that of the combination of fosfomycin and ciprofloxacin or levofloxacin. An ATP bioluminescence assay was used to evaluate the antibacterial activity of the agents against sessile cells in a mature biofilm developed on a silicon disk. The total bioactivity of P. aeruginosa growing in a biofilm that had not been fully eradicated by fosfomycin or any of the fluoroquinolones alone at 10 times the MIC decreased after combination treatment with fosfomycin and fluoroquinolones. Morphological changes occurred in a time-dependent fashion; namely, swollen and/or rounding cells emerged within a couple of hours after combination treatment, marking the initial stage in the process leading to the destruction of the biofilms. We could not find any difference among the 3 fluoroquinolones with regard to their synergistic effects when administered with fosfomycin. The combination treatment of fosfomycin and fluoroquinolones with highly potent antipseudomonal activities was effective in eradicating sessile cells of P. aeruginosa in the biofilm and promises to be beneficial against biofilm-associated infectious diseases.

Keywords
urinary tract infection
Pseudomonas aeruginosa
biofilm
ulifloxacin
fosfomycin
Amo Type
Article
Publication Title
Acta Medica Okayama
Published Date
2005-10
Volume
volume59
Issue
issue5
Publisher
Okayama University Medical School
Start Page
209
End Page
216
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
英語
File Version
publisher
Refereed
True
PubMed ID
Web of Science KeyUT